ropinirole has been researched along with prochlorperazine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Catana, C; Hooker, JM; Mandeville, JB; Rosen, BR; Sander, CY | 1 |
1 review(s) available for ropinirole and prochlorperazine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for ropinirole and prochlorperazine
| Article | Year |
|---|---|
Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI.
Topics: Animals; Brain; Dopamine Agonists; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Indoles; Macaca mulatta; Magnetic Resonance Imaging; Male; Models, Neurological; Positron-Emission Tomography; Prochlorperazine; Quinpirole; Receptors, Dopamine D2; Receptors, Dopamine D3 | 2016 |